PANELIST

Anna Casagrande
Director of Risk Management, Procurement Center of Excellence
Bristol-Myers Squibb 

Anna Casagrande is the Director of Risk Management at the Procurement Center of Excellence, Bristol-Myers Squibb. In this role, she is responsible for the implementation and execution of the company’s enterprise-wide third-party risk management program. She has over 23 years of leadership experience in procurement and operations. She joined Bristol-Myers Squibb in 2019 and has since held various leadership roles within Procurement. She has been instrumental in establishing the company’s supplier relationship management program and supplier risk management, with a specific focus on the supply chain for the Global Products Development & Supply Division.

Before her tenure at Bristol-Myers Squibb, Anna spent over 18 years at Pfizer’s Consumer Division, where she held numerous leadership roles with increasing responsibilities starting in 2001. During her time at Pfizer, she focused on network optimization, supply chain complexity reduction, supplier selection, and the implementation of various operational excellence approaches. Her initiatives were key in securing supply continuity and optimizing total cost of ownership (TCO).

In June 2014, Anna relocated to the US North America Region. In this capacity, she continued her work in developing effective and collaborative supplier relationships, network optimization, supply chain complexity reduction, sourcing and contracting activities and the implementation of innovative operational excellence approaches. Her efforts ensured supply continuity and TCO optimization, further solidifying her reputation as a leader in procurement and supply chain management.